Richard Norton, Actor and Martial Artist, Died After Peptide Injection Triggered Fatal Cardiac Arrest, Coroner Finds

Australian actor and martial artist Richard Norton, best known for his appearances in action films alongside Hollywood stars, died in March 2025 after an unapproved peptide injection triggered a severe allergic reaction that led to cardiac arrest, according to newly released coroner findings.

The findings, released on October 28, 2026, have raised fresh concerns about the safety of experimental peptide treatments promoted for muscle growth, recovery, and anti-aging.

Who Was Richard Norton?

Richard Norton was an Australian actor, martial artist, stuntman, and fight choreographer who built an impressive career in the international film industry.

Born in Australia, Norton became widely recognized for his martial arts skills and action-film performances. Throughout his career, he worked alongside well-known Hollywood stars, including Chuck Norris and Jackie Chan.

He also contributed to major film productions as a stunt performer and fight choreographer, including Mad Max: Fury Road and Suicide Squad.

Norton was 75 years old when he died at Melbourne's Alfred Hospital on March 30, 2025.

What Happened Before His Death?

According to findings by Victorian Coroner David Ryan, Norton had been interested in peptide therapy to address several health and fitness concerns, including fatigue, shoulder pain, slower physical recovery, and loss of muscle mass.

He was prescribed two unapproved peptide products: CJC-1295 and Ipamorelin.

The treatment was discussed as experimental, and Norton signed an informed consent form acknowledging its potential risks.

However, the coroner's findings revealed that Norton had been taking more than the prescribed amount. He reportedly told a nurse at the medical clinic that he had been administering double the recommended dose.

On March 28, 2025, Norton became unresponsive after injecting the peptides. He was taken to hospital but died two days later.

What Did the Coroner Discover?

The coroner concluded that the peptide injection triggered an anaphylactic reaction, a severe allergic reaction that led to cardiac arrest.

The findings also identified asthma and hypertrophic cardiomyopathy as contributing factors.

The investigation highlighted concerns about the limited scientific evidence supporting the safety and effectiveness of CJC-1295 and Ipamorelin in humans.

The case has become an important example of the potential risks associated with experimental treatments that have not undergone the necessary regulatory assessment.

Why Are Peptide Treatments Raising Concerns?

Peptides are short chains of amino acids that play various roles in the human body. Some peptide-based medicines have established medical uses and regulatory approval.

However, other products are promoted online for purposes such as muscle development, weight management, recovery, and anti-aging without sufficient evidence of safety or effectiveness.

Health authorities have repeatedly warned that unapproved products may have uncertain quality, safety, and manufacturing standards.

Norton's death has brought additional attention to the need for stronger oversight and reliable scientific evidence before experimental treatments are widely promoted.

Coroner Calls for Stronger Regulations

Following the investigation, Coroner David Ryan recommended that Australia's Therapeutic Goods Administration (TGA) review the potential benefits and safety risks of peptides such as CJC-1295 and Ipamorelin.

The recommendation also raised the possibility of introducing stricter restrictions on their availability.

The TGA has stated that unapproved peptide products have not been assessed for safety, quality, or effectiveness and that it continues to examine potential regulatory measures.

The case has also prompted wider discussions about medical supervision, prescribing practices, and the responsibilities of healthcare professionals.